Global Neuroprotection Markets, Drugs and Companies,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
26
Global Neuroprotection Markets, Drugs and Companies, 2017-2026

Dublin, Oct. 05, 2017 (GLOBE NEWSWIRE) -- The "Neuroprotection - Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many of the underlying mechanisms of damage to neural tissues are similar in all these conditions and several products are used in more than one disorder.

Over 500 products have been investigated for neuroprotective effects including those from the categories of free radical scavengers, anti-excitotoxic agents, apoptosis (programmed cell death) inhibitors, anti-inflammatory agents, neurotrophic factors, metal ion chelators, ion channel modulators and gene therapy. Some of the agents are old established pharmaceuticals whereas others are new biotechnology products.

Pathomechanisms of diseases are described with steps at which neuroprotective therapies are directed. Diseases covered include cerebrovascular disorders, traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy and ischemic optic neuropathy as well as retinal degeneration. Although anesthetics such as propofol are neuroprotective as well, neuroprotection during surgery and anesthesia is discussed with the aim of preventing and treating complications that result in CNS damage.

The report contains profiles of 141 companies that have a neuroprotective product or products along with 117 collaborations. Some of the products in development at academic institutions that do not have a commercial sponsor are also included. Although an up-to-date search of the literature was performed and selected 1,100 references are included. Clinical trials of various neuroprotective agents are described and failures of trials are analyzed with suggestions for improving the selection of drugs and design of trials.The report is supplemented with 80 tables and 19 figures.

Market analysis of currently used products that have a neuroprotective effect are analyzed for the year 2016. Some of these products are approved for other indications but are known to have a neuroprotective effect. With the approval of new products and takeover of markets for obsolete symptomatic therapies, the neuroprotection market value will rise by the year 2021 when it will constitute a major and important component of the CNS market. Forecasts are made until 2026. By that time neuroprotection will be an established part of the neurological practice and measures will be available to achieve this effectively.

Key Topics Covered:

Part I: Drugs & Markets Executive Summary 1. Introduction 2. Neuroprotective Agents 3. Neuroprotection in Cerebrovascular Disease 4. Neuroprotection in Traumatic Brain Injury 5. Neuroprotection in Spinal Cord Injury 6. Neuroprotection in Neurodegenerative Disorders 7. Neuroprotection in Parkinson Disease 8. Neuroprotection in Alzheimer Disease 9. Neuroprotection in Huntington Disease 10. Neuroprotection in Amyotrophic Lateral Sclerosis 11. Neuroprotection in Miscellaneous Neurological Disorders 12. Neuroprotection of the Optic nerve and the Retina 13. Neuroprotection during Anesthesia and Surgery 14. Markets for Neuroprotective Therapies 15. References Part II: Companies 16. Companies Developing Neuroprotective Therapies

For more information about this report visit https://www.researchandmarkets.com/research/s...protection

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Central Nervous System Drugs

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sinopec Unveils Biodiversity Report at COP17

Updated Category News Views 47

Sinopec's First Step on the Global Biodiversity Stage Seems like Sinopec (HKG: 0386) has decided to toss its hat into the biodiversity conservation ring. At COP17 in Armenia, they released their inaugural Global Biodiversity Conservation Report—an event that marks more than just a company selling oil and gas. Now, they're talking wildlife and ecologies. Is that irony,...

Continue Reading
Veteran Surge in 2026 Midterm Elections: A New Wave

Updated Category News Views 43

A Swell of Veteran Candidates Hits the Midterm Shores Just when you think you've seen it all in politics, here comes another twist. As the 2026 midterms gear up, an impressive 258 military veterans are throwing their hats into the congressional ring. That's a jump up from 213 just two years back, and let me tell you, it's not just a numbers game—it's a sea change. Women...

Continue Reading
HIZENERGY Sustains Tier 1 Status Amid Tighter Criteria

Updated Category News Views 90

Another Feather in HIZENERGY's Cap In a landscape where credibility can make or break a business, HIZENERGY has once again staked its claim as a powerhouse. Come Q4 2026, and despite a rougher sea to navigate with BloombergNEF’s (BNEF) upgraded Tier 1 criteria, the company held its own. For those unacquainted, securing a place on this lofty list involves some serious...

Continue Reading
New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 217

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
ENGWE Unleashes Massive Black Friday E-Bike Discounts

Updated Category News Views 70

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Continue Reading
Cleafy's Cyber-Fraud Edge in SPARK Matrix™ 2026

Updated Category News Views 0

What's Cookin'? Cleafy Leads in Fraud Management Lineup Eying the world through a prism of calculated risk and opportunity, Cleafy has emerged a big dog in the latest QKS Group SPARK Matrix™ for Enterprise Fraud Management, 2026. The spotlight's on their cutting-edge knack for dodging cyber fraud's punches, a distinction that hints at a deeper market shift for those who...

Continue Reading
Perion Acquisition: Affle's Bold Leap in Ad Tech

Updated Category News Views 228

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Continue Reading
Isinwheel's 2027 E-Mobility Pitch: Beyond Resolutions

Updated Category News Views 163

Embracing the E-Mobility Shift Here we are at the tail end of 2026, and isinwheel is riding high on the wave of New Year resolutions with their hefty e-mobility lineup. It's not just about buying the gear—it's about tackling our reliance on gas-guzzlers with electric scooters and bikes as our trusty steeds. "Reduce car trips? More greenery in your commute? These aren't...

Continue Reading
Stellantis Harnesses AI for Customer Connection Boost

Updated Category News Views 0

Trading Mayhem: Pre-Market Vibes Ever put your ear to the ground on the NYSE floor and felt that buzz of untamed optimism clashing with skepticism? Today it's all about connections, from the data-driven to the familial. Imagine Stellantis (NYSE: STLA) is making a play, aligning with Amperity in an ambitious attempt to make customer interactions feel more personal. Now,...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 160

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading

Top 5 Most Recently Viewed Articles

Rural Healthcare Transformation: Data-Driven Innovations in Practice

Updated Category News Views 234

Revolutionizing Rural Healthcare with Data-Driven Solutions REDi Health Analytics, LLC ("REDi Health") has forged a partnership with a state health department to significantly boost the data capacity of six rural hospitals. Their goal is to enhance healthcare delivery and bridge the health disparities prevalent in rural communities. As highlighted by John Wadsworth,...

Continue Reading
Boeing Charges Union with Unfair Labor Practices Amid Strikes

Updated Category News Views 194

Boeing Takes Action Against Striking Union Boeing, a leading name in aerospace manufacturing, has recently initiated a charge of unfair labor practices against the union representing approximately 33,000 West Coast factory workers. This action highlights the ongoing tensions amid the strike that has disrupted operations. Allegations of Bad Faith Bargaining The charge was...

Continue Reading
Deckers Outdoor Adjusts to Split with New Price Target Set

Updated Category News Views 58

Deckers Outdoor Stock Price Target Update Recently, Evercore ISI made headlines by revising its price target for the shares of Deckers Outdoor (NYSE: DECK), adjusting it down to $183 from the previous level of $1,100. This reduction, while significant, comes after the company undertook a 6-for-1 stock split, a move aimed at making the stock more appealing to investors....

Continue Reading
Beam Therapeutics Welcomes Sravan Emany as New CFO

Updated Category News Views 247

Beam Therapeutics Welcomes a New Chief Financial Officer Beam Therapeutics Inc. (Nasdaq: BEAM), a leader in developing precision genetic medicines, is heralding an important new chapter in its journey with the appointment of Sravan K. Emany as its Chief Financial Officer (CFO). Bringing vast experience from his previous roles in well-established corporations, Mr. Emany is...

Continue Reading
Keysight Technologies Partners with UL Solutions for Certification

Updated Category News Views 192

Keysight Technologies, Inc. (NYSE: KEYS) made headlines by securing its role as a test partner for Thunderbolt 5 certification back in 2024. This partnership with UL Solutions is no small feat—it's a strategic play that puts Keysight squarely in the fast lane of advanced connectivity. As the landscape shifts, this collaboration hints at what’s coming: faster speeds...

Continue Reading